05.04.2023 - ALPHARETTA, Ga., April 05, 2023 (GLOBE NEWSWIRE) - Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS), today announced the . Seite 1
/PRNewswire/ Vial s tech-enabled CRO has added Marcia Swank to the team. Marcia will be the company s new VP of Ophthalmology. Swank joins the team with.
/PRNewswire/ Vial, a next-generation CRO, site network and technology platform, recently announced the planned launch of an Ophthalmology CRO. As part of.
/PRNewswire/ Vial, a next-generation CRO, site network and technology platform, recently announced the planned launch of an Ophthalmology CRO. As part of.